Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes

Summary Cardiac regenerative therapies utilizing human induced pluripotent stem cells (hiPSCs) are hampered by ineffective large-scale culture. hiPSCs were cultured in multilayer culture plates (CPs) with active gas ventilation (AGV), resulting in stable proliferation and pluripotency. Seeding of 1 × 106 hiPSCs per layer yielded 7.2 × 108 hiPSCs in 4-layer CPs and 1.7 × 109 hiPSCs in 10-layer CPs with pluripotency. hiPSCs were sequentially differentiated into cardiomyocytes (CMs) in a two-dimensional (2D) differentiation protocol. The efficiency of cardiac differentiation using 10-layer CPs with AGV was 66%–87%. Approximately 6.2–7.0 × 108 cells (4-layer) and 1.5–2.8 × 109 cells (10-layer) were obtained with AGV. After metabolic purification with glucose- and glutamine-depleted and lactate-supplemented media, a massive amount of purified CMs was prepared. Here, we present a scalable 2D culture system using multilayer CPs with AGV for hiPSC-derived CMs, which will facilitate clinical applications for severe heart failure in the near future.

[1]  Robert Zweigerdt,et al.  Scalable expansion of human pluripotent stem cells in suspension culture , 2011, Nature Protocols.

[2]  Christine L Mummery,et al.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. , 2012, Circulation research.

[3]  M. Suematsu,et al.  Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. , 2016, Cell metabolism.

[4]  Marta M. Silva,et al.  Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization , 2015, Stem cells translational medicine.

[5]  T. Graf Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[6]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[7]  A. Lam,et al.  Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture , 2014, Stem Cell Research & Therapy.

[8]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[9]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .

[10]  S. Yuasa,et al.  A Massive Suspension Culture System With Metabolic Purification for Human Pluripotent Stem Cell‐Derived Cardiomyocytes , 2014, Stem cells translational medicine.

[11]  S. Reuveny,et al.  Long-term microcarrier suspension cultures of human embryonic stem cells. , 2009, Stem cell research.

[12]  A. Lam,et al.  Cationic surface charge combined with either vitronectin or laminin dictates the evolution of human embryonic stem cells/microcarrier aggregates and cell growth in agitated cultures. , 2014, Stem cells and development.

[13]  Robert Zweigerdt,et al.  Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. , 2012, Tissue engineering. Part C, Methods.

[14]  Eugenia Kumacheva,et al.  Generation of human embryonic stem cell‐derived mesoderm and cardiac cells using size‐specified aggregates in an oxygen‐controlled bioreactor , 2009, Biotechnology and bioengineering.

[15]  Josef Stehlik,et al.  The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  Allan J. Robins,et al.  A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells , 2012, PloS one.

[17]  Robert Zweigerdt,et al.  Large-scale production of human pluripotent stem cell derived cardiomyocytes. , 2016, Advanced drug delivery reviews.

[18]  Andre Choo,et al.  Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. , 2010, Tissue engineering. Part C, Methods.

[19]  Robert Zweigerdt,et al.  Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. , 2010, Stem cell research.

[20]  M. S. Kallos,et al.  Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. , 2010, Tissue engineering. Part C, Methods.

[21]  S. Reuveny,et al.  Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. , 2011, Tissue engineering. Part C, Methods.

[22]  Giovanni Staurenghi,et al.  Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. , 2017, The New England journal of medicine.

[23]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[24]  Tiago G Fernandes,et al.  Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems , 2016, PloS one.

[25]  遠山 周吾 Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes , 2013 .

[26]  Sean P. Palecek,et al.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.

[27]  Catarina Brito,et al.  Process engineering of human pluripotent stem cells for clinical application. , 2012, Trends in biotechnology.

[28]  T. Putti,et al.  Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. , 2009, Stem cell research.

[29]  S. Reuveny,et al.  An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures. , 2014, Stem cell research.

[30]  Robert Zweigerdt,et al.  Controlling Expansion and Cardiomyogenic Differentiation of Human Pluripotent Stem Cells in Scalable Suspension Culture , 2014, Stem cell reports.

[31]  J. Sznajder,et al.  Elevated CO2 Levels Cause Mitochondrial Dysfunction and Impair Cell Proliferation* , 2011, The Journal of Biological Chemistry.

[32]  R. McKay,et al.  Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. , 2014, Cell stem cell.

[33]  Tiago G Fernandes,et al.  Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems. , 2016, Journal of Biotechnology.